Zevin Asset Management LLC reduced its position in shares of Danaher Corporation (NYSE:DHR) by 8.0% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 71,284 shares of the conglomerate’s stock after selling 6,206 shares during the quarter. Danaher Corporation accounts for approximately 1.4% of Zevin Asset Management LLC’s investment portfolio, making the stock its 26th biggest holding. Zevin Asset Management LLC’s holdings in Danaher Corporation were worth $6,115,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of DHR. GQG Partners LLC bought a new position in shares of Danaher Corporation in the second quarter valued at about $101,000. Proficio Capital Partners LLC grew its stake in shares of Danaher Corporation by 92.3% in the first quarter. Proficio Capital Partners LLC now owns 1,246 shares of the conglomerate’s stock valued at $105,000 after acquiring an additional 598 shares in the last quarter. Monetary Management Group Inc. grew its stake in shares of Danaher Corporation by 10.7% in the second quarter. Monetary Management Group Inc. now owns 1,550 shares of the conglomerate’s stock valued at $131,000 after acquiring an additional 150 shares in the last quarter. Acrospire Investment Management LLC grew its stake in shares of Danaher Corporation by 185.5% in the second quarter. Acrospire Investment Management LLC now owns 1,693 shares of the conglomerate’s stock valued at $143,000 after acquiring an additional 1,100 shares in the last quarter. Finally, ClariVest Asset Management LLC acquired a new position in shares of Danaher Corporation in the first quarter valued at about $157,000. 75.38% of the stock is currently owned by hedge funds and other institutional investors.

In other news, CFO Daniel L. Comas sold 88,184 shares of Danaher Corporation stock in a transaction on Monday, October 23rd. The stock was sold at an average price of $91.02, for a total transaction of $8,026,507.68. Following the sale, the chief financial officer now directly owns 227,816 shares in the company, valued at approximately $20,735,812.32. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Thomas Patrick Joyce, Jr. sold 125,989 shares of Danaher Corporation stock in a transaction on Wednesday, November 1st. The stock was sold at an average price of $92.64, for a total value of $11,671,620.96. Following the sale, the chief executive officer now owns 271,737 shares in the company, valued at $25,173,715.68. The disclosure for this sale can be found here. Insiders have sold a total of 279,628 shares of company stock worth $25,304,394 over the last quarter. Company insiders own 12.20% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: “Zevin Asset Management LLC Has $6.12 Million Holdings in Danaher Corporation (DHR)” was published by Daily Political and is owned by of Daily Political. If you are viewing this news story on another site, it was illegally copied and republished in violation of United States & international trademark & copyright laws. The original version of this news story can be viewed at https://www.dailypolitical.com/2017/11/17/zevin-asset-management-llc-has-6-12-million-holdings-in-danaher-corporation-dhr.html.

Several research firms recently commented on DHR. Robert W. Baird upped their price target on shares of Danaher Corporation from $87.00 to $97.00 and gave the company an “outperform” rating in a research note on Friday, October 20th. Morgan Stanley upped their price target on shares of Danaher Corporation from $95.00 to $98.00 and gave the company an “overweight” rating in a research note on Friday, October 20th. Credit Suisse Group increased their price objective on shares of Danaher Corporation from $93.00 to $96.00 and gave the stock an “outperform” rating in a research note on Friday, October 20th. Zacks Investment Research upgraded shares of Danaher Corporation from a “hold” rating to a “buy” rating and set a $97.00 price objective on the stock in a research note on Thursday, October 5th. Finally, J P Morgan Chase & Co reiterated an “overweight” rating and set a $95.00 price objective on shares of Danaher Corporation in a research note on Friday, September 8th. One analyst has rated the stock with a sell rating, four have issued a hold rating, thirteen have issued a buy rating and one has issued a strong buy rating to the stock. The stock currently has an average rating of “Buy” and a consensus target price of $93.31.

Danaher Corporation (NYSE:DHR) opened at $93.58 on Friday. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.00 and a current ratio of 1.43. The stock has a market cap of $64,287.83, a price-to-earnings ratio of 23.76, a price-to-earnings-growth ratio of 2.20 and a beta of 1.02. Danaher Corporation has a fifty-two week low of $76.27 and a fifty-two week high of $93.86.

Danaher Corporation (NYSE:DHR) last released its earnings results on Thursday, October 19th. The conglomerate reported $1.00 EPS for the quarter, topping the Zacks’ consensus estimate of $0.95 by $0.05. The company had revenue of $4.53 billion for the quarter, compared to analysts’ expectations of $4.47 billion. Danaher Corporation had a return on equity of 11.29% and a net margin of 13.36%. The business’s revenue for the quarter was up 9.6% compared to the same quarter last year. During the same period in the previous year, the business posted $0.87 EPS. sell-side analysts anticipate that Danaher Corporation will post 3.99 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which was paid on Friday, October 27th. Stockholders of record on Friday, September 29th were paid a dividend of $0.14 per share. This represents a $0.56 dividend on an annualized basis and a dividend yield of 0.60%. The ex-dividend date was Thursday, September 28th. Danaher Corporation’s payout ratio is 16.52%.

Danaher Corporation Company Profile

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

Institutional Ownership by Quarter for Danaher Corporation (NYSE:DHR)

Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with MarketBeat.com's FREE daily email newsletter.